Label 20 mg · Tested Oct 13, 2026
Batch V261012-20 002 · Vanguard Laboratory
PDF · 224 KB
Designed to support faster recovery, tissue repair, joint health, and overall physical performance.
Select Variant
Selected price
$120.00
$139.99
Add $150.00 for free Canadian shipping.
Wolverine BPC-157 + TB-500 Product Overview Wolverine combines 10mg of BPC-157 and 10mg of TB-500 in a single lyophilized vial. The product provides 20mg of total material with both components supplied at a 1:1 mass ratio. This formulation is intended for controlled laboratory studies examining the individual and combined characteristics of BPC-157 and TB-500. Product Specifications: BPC-157: 10mg TB-500: 10mg Total material: 20mg Component ratio: 1:1 by mass Format: Lyophilized material Container: Single vial BPC-157 Research Background BPC-157 is a synthetic 15-amino-acid peptide. Published preclinical research has examined its properties in experimental models involving cell migration, tendon fibroblasts, vascular signalling and connective-tissue response. The existing literature consists primarily of laboratory and animal studies. Results from these studies should not be interpreted as evidence of safety or therapeutic effectiveness in humans. TB-500 Research Background TB-500 is a thymosin beta-4-related research material. Scientific research involving thymosin beta-4 and related peptide fragments has investigated actin binding, cytoskeletal organization, endothelial response and cell migration. The term TB-500 is not always used consistently across the research-material market. Researchers should verify the exact identity, sequence, purity and analytical specifications shown in the documentation for the individual batch. Studying the Combined Formulation BPC-157 and TB-500 are frequently combined under the informal product name “Wolverine.” Supplying both components in one vial allows the formulation to be examined in controlled laboratory experiments alongside appropriate component-only and control samples. Published findings concerning either component individually do not establish that a combined formulation produces a synergistic effect. Any interaction between the components must be evaluated through an appropriate experimental design. Potential Research Areas Comparative analysis of the combined formulation and individual components Cell-migration assays Cytoskeletal-response studies Endothelial and vascular-signalling models Connective-tissue and extracellular-matrix research Formulation compatibility and stability analysis Analytical identity and purity testing Storage Store the unopened vial according to the conditions stated on the product label and applicable batch documentation. Keep the material sealed and protected from light, heat and moisture. For laboratory research only. Not for human consumption or veterinary use. This product is not a drug, medication, supplement or cosmetic and is not intended to diagnose, treat, cure or prevent any disease.
No reviews yet. Be the first.
No reviews yet — yours could be first.
Yes. Product pages, cart, and checkout use the current catalog data for active variants, availability, prices, and totals.
Canadian orders ship free when the merchandise subtotal is at least $150 CAD. Orders below that threshold use a flat $25.00 CAD shipping charge.
Checkout creates a pending order. The order is confirmed only after the e-transfer is reviewed and marked paid by an admin.
Contact Nuforme as soon as possible. Orders should be reviewed carefully before checkout because fulfillment starts after payment is confirmed.
BPC-157 (Body Protection Compound-157) is a synthetic peptide made up of 15 amino acids. Its sequence is based on a partial segment of a protective protein found in human gastric juice, and the synthetic form was developed for greater stability than the naturally occurring compound.
Cartalax is a synthetic tetrapeptide with the sequence Alanine-Glutamic acid-Aspartic acid-Glycine, commonly abbreviated AEDG. It belongs to the family of short peptides developed by Russian gerontologist Vladimir Khavinson, often referred to as Khavinson peptides or peptide bioregulators.
CJC-1295 + Ipamorelin is a peptide combination studied in research focused on growth hormone pathways and the interaction between GHRH and ghrelin receptor signaling.
Editorial guidance only — current pricing and stock live on each product page.
When recovery feels slower than it once did, bold claims can be tempting. The published human record for BPC-157 is far smaller—and less relevant to injury recovery—than its reputation suggests.
Read article
When a tendon injury lingers, it is natural to look for a clearer answer. The published comparison between these peptides is far narrower than online discussion suggests.
Read article
KPV appears repeatedly in gut-inflammation models, but FDA reviewers found no human exposure, safety, pharmacokinetic, or efficacy data.
Read articleWolverine (BPC-157 + TB-500)
$120.00
